1) 21 hydroxylase deficiency
21羟化酶缺陷症
1.
Objective Clinical data of 19 Chinese patients with 21 hydroxylase deficiency (21OHD) were analyzed to improve the diagnosis and treatment level.
目的分析19例21羟化酶缺陷症(21OHD)患者的临床和随访资料,提高该病的诊断和治疗水平。
2) 21-hydroxylase deficiency
21-羟化酶缺陷症
1.
Right adrenal "tumor-like" hyperplasia in an adult with 21-hydroxylase deficiency—a case report.
21-羟化酶缺陷症伴右肾上腺“瘤样”增生1例
3) 21-hydroxylase deficiency
21-羟化酶缺乏症
1.
Genotype and clinical characteristics of Chinese patients with nonclassical steroid 21-hydroxylase deficiency;
非经典型21-羟化酶缺乏症基因型和临床特征
2.
The major cause of CAH is 21-hydroxylase deficiency (21-OHD), which accounts for 90%～95% of all cases in most populations.
目的： 21-羟化酶缺乏症(21-hydroxylase deficiency，21-OHD)是先天性肾上腺皮质增生症(congenital adrenal hyperplasia，CAH)中最常见的一种类型，属于常染色体隐性遗传性疾病。
5) 11 beta-hydroxylase deficiency
11β-羟化酶缺陷症
1.
Clinical characteristics and treatment of 11 beta-hydroxylase deficiency-report of 9 cases and literature review;
11β-羟化酶缺陷症9例临床特征与治疗分析
6) 17α-Hydroxylase Deficiency
17α-羟化酶缺陷症
1.
Clinical Analysis for 9 Patients with 17α-Hydroxylase Deficiency;
17α-羟化酶缺陷症的九例临床分析
补充资料：21-羟化酶缺陷
21-羟化酶缺陷
表现为失盐型，因盐皮质激素的合成受阻而肾脏无法保钠，出现低钠血症，表现为纳差、严重呕吐、脱水，以致威胁生命。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条